{"id":"NCT01153893","sponsor":"GlaxoSmithKline","briefTitle":"Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Nigeria","officialTitle":"Safety, Reactogenicity and Immunogenicity Study of GSK Biologicals' Pneumococcal Vaccine GSK1024850A, Given Either as a Booster Dose or as a 2-dose Catch-up Immunization in Healthy Nigerian Children","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-10-04","primaryCompletion":"2011-02-16","completion":"2011-02-16","firstPosted":"2010-06-30","resultsPosted":"2012-03-15","lastUpdate":"2018-09-20"},"enrollment":105,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Infections, Streptococcal"],"interventions":[{"type":"BIOLOGICAL","name":"Pneumococcal vaccine GSK1024850A","otherNames":[]},{"type":"BIOLOGICAL","name":"InfanrixTM","otherNames":["DTPa"]}],"arms":[{"label":"Synflorix/Infanrix primed Group","type":"EXPERIMENTAL"},{"label":"Synflorix/Infanrix unprimed Group","type":"EXPERIMENTAL"}],"summary":"The purpose of this trial is to assess the safety, reactogenicity and immunogenicity of GSK Biologicals' pneumococcal conjugate vaccine GSK1024850A when administered either as a booster dose or as a two dose catch-up vaccination in the second year of life to the Nigerian subjects previously enrolled in the primary vaccination study NCT00678301.\n\nThis protocol posting deals with objectives \\& outcome measures of the booster phase. The objectives \\& outcome measures of the primary phase are presented in a separate protocol posting (NCT number = NCT00678301).","primaryOutcome":{"measure":"Number of Subjects Reporting Grade 3 Symptoms (Solicited and Unsolicited).","timeFrame":"Within 31 days (Day 0 to Day 30) after administration of a booster dose of Synflorix vaccine in the Synflorix/Infanrix primed Group.","effectByArm":[{"arm":"Synflorix/Infanrix Primed Group","deltaMin":3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"15 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":12},"locations":{"siteCount":1,"countries":["Nigeria"]},"refs":{"pmids":["24356787"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":68},"commonTop":["Pain","Respiratory tract infection","Malaria","Fever","Swelling"]}}